- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02588066
Pancreatoduodenectomy With or Without Ligamentum Teres Wrap Around Gastroduodenal Artery Stump for Prevention of Pancreatic Hemorrhage
February 4, 2021 updated by: Technische Universität Dresden
Pancreatoduodenectomy With or Without Prophylactic Ligamentum Teres Hepatic Wrap Around the Gastroduodenal Artery Stump for Prevention of Pancreatic Hemorrhage - Panda - Multicentric Randomized Controlled Trial
To investigate, whether a prophylactic wrapping of the gastroduodenal artery stump with the ligamentum teres or falciform hepatic (embryological structures, covered with peritoneum that do not have relevant meaning for adults) can reduce the incidence of arrosion bleeding during surgery.
Thus a surgical technique is evaluated prospectively.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Pancreatoduodenectomy is a standard surgical procedure for resection of tumors of the pancreatic head and neck, and for selected patients with chronic pancreatitis.
A postoperative pancreatic fistula (POPF) is a severe and frequent complication that may lead to a potentially letal arrosion hemorrhage from the stump of the gastroduodenal artery (GDA).
Aim of the study is to evaluate the prophylactic wrapping of the GDA stump using the falciform hepatic ligament during the index operation.
The null hypothesis is that prophylactic wrapping does not decrease the incidence of arrosion hemorrhage from the GDA stump.
The study is designed as a randomized, single-blinded, controlled, multicenter trial.
Study Type
Interventional
Enrollment (Actual)
400
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Dresden, Germany
- Department of Surgery, University Hospital Dresden
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Indication for elective open pancreatoduodenectomy (pylorus-preserving or classic) with pancreatojejunostomy for tumors, or cystic lesions of the pancreatic head, tumors of the distal bile duct, duodenum or for chronic pancreatitis
- american society of anesthesiologists classification I-III
- age ≥18 years
- given informed consent
Exclusion Criteria:
- status post previous abdominal surgery with resection of the falciform ligament (e.g. hemihepatectomy)
- No reconstruction using a pancreatojejunostomy (e.g. pancreatogastrostomy)
- simultaneous visceral arterial resection
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: SINGLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
EXPERIMENTAL: Index test
Ligamentum teres/falciform-plasty around the gastroduodenal artery stump during pancreatoduodenectomy
|
Ligamentum teres/falciform-plasty around the gastroduodenal artery stump during pancreatoduodenectomy
|
|
NO_INTERVENTION: Reference test
No Ligamentum teres/falciform-plasty around the gastroduodenal artery stump during pancreatoduodenectomy
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Incidence of arrosion bleeding
Time Frame: >24 hours after partial pancreatoduodenectomy
|
>24 hours after partial pancreatoduodenectomy
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Thilo Welsch, Department of Visceral, Thoracic and Vascular Surgery, University Hospital Carl Gustav Carus, TU Dresden, Germany
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Welsch T, Mussle B, Korn S, Sturm D, Bork U, Distler M, Grahlert X, Klimova A, Trebesius N, Kleespies A, Kees S, Beckert S, Reim D, Friess H, Elwerr M, Kleeff J, Popescu O, Schmitz-Winnenthal H, Janot-Matuschek M, Uhl W, Weber GF, Brunner M, Golcher H, Grutzmann R, Weitz J. Pancreatoduodenectomy with or without prophylactic falciform ligament wrap around the hepatic artery for prevention of postpancreatectomy haemorrhage: randomized clinical trial (PANDA trial). Br J Surg. 2021 Dec 17;109(1):37-45. doi: 10.1093/bjs/znab363.
- Mussle B, Zuhlke L, Wierick A, Sturm D, Grahlert X, Distler M, Rahbari NN, Weitz J, Welsch T. Pancreatoduodenectomy with or without prophylactic falciform ligament wrap around the gastroduodenal artery stump for prevention of pancreatectomy hemorrhage. Trials. 2018 Apr 12;19(1):222. doi: 10.1186/s13063-018-2580-0.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
November 1, 2015
Primary Completion (ACTUAL)
June 1, 2020
Study Completion (ACTUAL)
July 1, 2020
Study Registration Dates
First Submitted
October 26, 2015
First Submitted That Met QC Criteria
October 26, 2015
First Posted (ESTIMATE)
October 27, 2015
Study Record Updates
Last Update Posted (ACTUAL)
February 5, 2021
Last Update Submitted That Met QC Criteria
February 4, 2021
Last Verified
February 1, 2021
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- TW-002
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pancreatoduodenectomy
-
University Hospital, MontpellierUniversité MontpellierCompletedPancreatoduodenectomy
-
Changhai HospitalCompleted
-
Fundacion Miguel ServetCompletedPancreatoduodenectomySpain
-
Peking Union Medical College HospitalUnknown
-
Institut d'Investigació Biomèdica de Girona Dr....RecruitingPostoperative Pancreatic Fistula Post-pancreatoduodenectomySpain
-
The Cleveland ClinicEthicon, Inc.RecruitingPancreatoduodenectomy | Whipple ProcedureUnited States
-
Wakayama Medical UniversityUnknownPatients Who Undergo PancreatoduodenectomyJapan
-
Linkoeping UniversityLandspitali University HospitalCompletedPancreatectomy | Pancreatoduodenectomy | Distal Pancreatectomy (DP)
-
Institute of Liver and Biliary Sciences, IndiaCompletedPancreatoduodenectomyIndia
-
Fudan UniversityRecruitingPancreatic Cancer | Periampullary Carcinoma | PancreatoduodenectomyChina
Clinical Trials on Ligamentum teres/falciform-plasty
-
Andrew MokbelNot yet recruitingEffect of Ligamentum Teres in Hiatus HerniaEgypt
-
Assiut UniversityNot yet recruitingOrthopaedic Surgery
-
Al-Azhar UniversityNot yet recruitingOrthopedic Disorder
-
Al-Azhar UniversityNot yet recruitingOrthopedic Disorder
-
GEM Hospital & Research CenterUnknown
-
Hossam Mahmoud IbrahimAssiut UniversityNot yet recruitingObesity and Obesity-related Medical Conditions